Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasm Female × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Ovarian Neoplasms 6 Central Nervous System Neoplasms 5 Retinoblastoma 4 Lung Neoplasms 4 Fallopian Tube Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Spinal Cord Neoplasms 2 Small Cell Lung Carcinoma 2 Oligodendroglioma 2 Neuroblastoma 2 Neoplasms 2 Lymphoma 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Vomiting 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Stage IA Uterine Sarcoma 1 Solid Tumor Cancer 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Ovarian Germ Cell Cancer 1 Osteosarcoma 1 Optic Nerve Glioma 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

pyrotinib 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Ondansetron 1 Morphine 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06234137 2024-01-31

neoPICD

First Affiliated Hospital of Wenzhou Medical University

Phase NA Recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡